← Back to Screener
Cypherpunk Technologies Inc. Common Stock (CYPH)
Price$0.87
Favorite Metrics
Price vs S&P 500 (26W)28.00%
Price vs S&P 500 (4W)14.45%
Market Capitalization$78.17M
All Metrics
Book Value / Share (Quarterly)$1.83
Cash Flow / Share (Quarterly)$-0.52
Price vs S&P 500 (YTD)-28.81%
Net Profit Margin (TTM)-2705.80%
EPS (TTM)$-0.60
10-Day Avg Trading Volume2.97M
EPS Excl Extra (TTM)$-0.60
EPS (Annual)$-1.80
ROI (Annual)-192.75%
Cash / Share (Quarterly)$0.17
P/E Basic Excl Extra (TTM)16.21x
ROA (Last FY)-137.52%
EBITD / Share (TTM)$-0.58
ROE (5Y Avg)-103.49%
Operating Margin (TTM)-2761.73%
Cash Flow / Share (Annual)$-0.52
P/B Ratio0.51x
P/B Ratio (Quarterly)0.43x
Net Income / Employee (Annual)$-1
Net Interest Coverage (TTM)-97.81x
ROA (TTM)8.40%
EPS Incl Extra (Annual)$-1.80
Current Ratio (Annual)35.56x
Quick Ratio (Quarterly)35.55x
3-Month Avg Trading Volume3.37M
52-Week Price Return136.80%
P/E Incl Extra (TTM)16.21x
Revenue / Employee (TTM)$0
P/S Ratio (Annual)52.11x
Asset Turnover (Annual)0.01x
52-Week High$3.70
EPS Excl Extra (Annual)$-1.80
26-Week Price Return36.74%
Quick Ratio (Annual)35.55x
13-Week Price Return-23.35%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)35.56x
Enterprise Value$64.13
Asset Turnover (TTM)0.02x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-2707.40%
Cash / Share (Annual)$0.17
3-Month Return Std Dev143.44%
Net Income / Employee (TTM)$0
ROE (Last FY)-192.75%
Net Interest Coverage (Annual)-26.47x
EPS Basic Excl Extra (Annual)$-1.80
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.60
ROI (TTM)10.55%
P/S Ratio (TTM)52.11x
Revenue / Share (Annual)$0.00
Price vs S&P 500 (52W)101.71%
P/E Ratio (TTM)16.21x
Year-to-Date Return-24.67%
5-Day Price Return-11.75%
EPS Normalized (Annual)$-1.80
ROA (5Y Avg)-82.39%
Net Profit Margin (Annual)-2705.80%
Month-to-Date Return9.91%
EBITD / Share (Annual)$-1.87
Operating Margin (Annual)-2761.73%
ROI (5Y Avg)-103.49%
P/E Excl Extra (TTM)16.21x
EPS Basic Excl Extra (TTM)$-0.60
P/B Ratio (Annual)0.43x
Pretax Margin (TTM)-2707.40%
Book Value / Share (Annual)$1.83
Price vs S&P 500 (13W)-26.22%
Beta-0.09x
Revenue / Share (TTM)$0.00
ROE (TTM)10.55%
52-Week Low$0.23
Analyst Recommendations
Dec 2025
Jan 2026
Feb 2026
Mar 2026
2.17
2.17
2.17
2.17
Industry Peers — Pharmaceuticals(309)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
CYPHCypherpunk Technologies Inc. Common Stock | 52.11x | — | — | — | $0.87 |
LLYEli Lilly & Co. | 13.45x | 44.70% | 83.04% | 27.59% | $919.90 |
JNJJohnson & Johnson | 5.82x | 7.87% | 67.95% | 14.90% | $230.69 |
ABBVABBVIE INC. | 5.97x | 8.57% | 71.62% | -2.88% | $203.71 |
MRKMerck & Co., Inc. | 4.51x | 1.31% | 78.55% | 21.23% | $117.10 |
AZNAstraZeneca PLC | 5.39x | 8.63% | 81.31% | 21.88% | $200.69 |
NVSNovartis AG | 4.87x | 8.91% | 75.82% | 15.26% | $150.99 |
NVONovo-Nordisk A/S | 3.74x | 6.43% | 80.98% | 20.66% | $40.46 |
ABTAbbott Laboratories | 3.71x | 6.59% | 56.50% | 8.20% | $96.00 |
PFEPfizer Inc. | 2.50x | -1.64% | 75.81% | -3.51% | $27.52 |
BMYBristol-Myers Squibb Co. | 2.52x | -0.22% | 72.63% | — | $59.13 |
About
Cypherpunk Technologies Inc develops novel therapies for cancer patients while maintaining a digital asset treasury concentrated in Zcash. The company combines oncology research and drug development with cryptocurrency asset management.